MASHINIi

PROCEPT BioRobotics Corporation.

PRCT.US | Manufacture of medical and dental instruments and supplies

PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing minimally invasive waterjet-based therapies. Their primary product, AquaBeam Robotic System, is used for the treatment of benign prostatic hyperplasia (BPH), a condition affecting many aging men. The AquaBeam system ...Show More

Ethical Profile

Mixed.

PROCEPT BioRobotics (PRCT.US) has a mixed ethical profile, offering Aquablation therapy for BPH as a less invasive option with clinical data suggesting sustained 5-year improvements, though reports suggest its higher cost limits accessibility. The company uses 37.5% renewable energy and 22.3% recycled materials. Its Aquabeam system reportedly cuts medical waste by 67.4% and saves 89.05 metric tons of CO2, though comprehensive environmental reporting is reportedly lacking. PROCEPT implements robust cybersecurity, complying with CCPA and Washington My Health My Data Act, and highlights ethical AI development. Information on fair pay, ethical sourcing, honest business, animal welfare, and community respect is currently insufficient.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect30
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-40
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products-40
-100100

Better Health for All

0

PROCEPT BioRobotics Corporation's core product, Aquablation therapy, is designed to treat benign prostatic hyperplasia (BPH), a prevalent condition in aging men.

1
Clinical studies consistently show that Aquablation therapy leads to significant improvements in the International Prostate Symptom Score (IPSS) and maximum urinary flow rate (Qmax) over 5 years, enhancing patients' quality of life and urinary function.
2
This indicates that the company's entire business is devoted to health improvement, with its offerings providing exceptional health benefits. There is no evidence of revenue from products with negative health outcomes. The company's safety record shows low rates of irreversible complications such as erectile dysfunction, ejaculatory dysfunction, and incontinence.
3
Surgical retreatment rates are low, with 96.3% freedom from secondary BPH procedures at 5 years in one study,
4
and transfusion rates are generally low (0.8-3.9%).
5
However, adverse events like bleeding requiring transfusion,
6
overactive bladder,
7
and rectal perforation have been reported.
8
The company's instructions for use (IFU) list these as potential risks.
9
Aquablation is currently more expensive than Transurethral Resection of the Prostate (TURP) due to equipment and physician costs.
10
During the COVID-19 pandemic, patient follow-up rates were impacted, with lower completion rates at 5 years.
11
The company conducts various clinical trials, including double-blind, prospective, randomized controlled trials and single-arm, prospective clinical trials,
12
which received Institutional Review Board (IRB) approval and obtained informed consent from participants.
13

Fair Money & Economic Opportunity

0

PROCEPT BioRobotics Corporation is a surgical robotics company focused on developing and marketing medical devices, specifically the AquaBeam Robotic System.

1
Its core business does not involve lending, insuring, moving, or storing money for consumers.
2
Therefore, all KPIs related to 'Fair Money & Economic Opportunity', which evaluate financial institutions and their services, are not applicable to this company's operations.
3

Fair Pay & Worker Respect

30

For fiscal year 2024, the CEO to median employee pay ratio was 38:1.

1
The company's employee engagement, based on 98 company reviews on Glassdoor, is rated at 4.1 out of 5 stars (82%).
2
PROCEPT BioRobotics offers a comprehensive benefits package to full-time employees and their dependents, including medical, dental, and vision coverage, a 401(k) retirement plan with company match, and an employee stock purchase plan.
3
Historically, all full-time employees have received equity awards where permissible.
4

Fair Trade & Ethical Sourcing

0

No evidence available to assess PROCEPT BioRobotics Corporation on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess PROCEPT BioRobotics Corporation on Honest & Fair Business.

Kind to Animals

0

No evidence available to assess PROCEPT BioRobotics Corporation on Kind to Animals.

No War, No Weapons

0

No evidence available to assess PROCEPT BioRobotics Corporation on No War, No Weapons.

Planet-Friendly Business

-40

PROCEPT BioRobotics currently sources 37.5% of its operational energy from renewables.

1
The company uses 22.3% recycled materials in its production processes.
2
No regulatory actions, violations, or fines are mentioned in the provided articles.
3
The company reported 2 work-related injuries/illnesses in 2022.
4
The company reported 4 in 2023.
5

Respect for Cultures & Communities

0

No evidence available to assess PROCEPT BioRobotics Corporation on Respect for Cultures & Communities.

Safe & Smart Tech

0

The company requires multi-factor authentication and encrypts communications via SSL protocols.

1
It conducts mandatory cybersecurity training for new employees, with follow-up training for those failing phishing tests, and adjusts materials based on testing outcomes.
2
The company performs periodic vulnerability testing and monitors network access.
3
Its privacy policy states that data is retained for the minimum necessary time, which can be up to 11 years in some cases.
4
Users have rights to access, delete, update, correct, restrict, and request portability of their data.
5
The company explicitly states compliance with the Washington My Health My Data Act (MHMDA) and the CCPA, and mentions compliance with FDA regulations for quality issues and adverse events.
6
It also states that it does not sell personal data.
7
Job postings for machine learning engineers emphasize the importance of explainable AI.
8

Zero Waste & Sustainable Products

-40

PROCEPT BioRobotics recycles 48.7% of its robotic system components.

1
The company uses 22.3% recycled materials in production and has a target to increase this to 40% by 2025.
2
It has achieved a 55.2% reduction in single-use instrument waste.
3
The company has reduced hazardous material by 62.1%.
4
Waste reduction initiatives include recycling cardboard packaging (10 tons in the first three months), reusing crates, donating unused furniture, and implementing reusable and compostable materials for employee food and drink.
5
The company has a target to reduce water conservation by 50% by 2027.
6
PROCEPT BioRobotics encourages suppliers to adopt similar environmental policies.
7
There have been no waste disposal violations in the past three years.
8

Own PROCEPT BioRobotics Corporation?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.